ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Clinical trials for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo aims to keep childhood leukemia away after transplant
Disease control Recruiting nowThis early-phase study tests whether an oral drug called ASTX727 (which combines cedazuridine and decitabine) plus a shot called filgrastim can safely help prevent leukemia from coming back in children who have already had a stem cell transplant for high-risk acute myeloid leukem…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
New hope for Hard-to-Treat leukemias: first human trial begins
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced types of leukemia (CMML or AML) that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. About 105 adults will take part in this first-in-human t…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug cocktails tested in younger patients
Disease control Recruiting nowThis study is for adults aged 59 and younger with a high-risk form of acute myeloid leukemia (AML) that is harder to treat. It compares the standard chemotherapy with several newer drug combinations to see which works better at shrinking the cancer. The goal is to find a more eff…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New screening tool aims to speed up cancer trial matching
Knowledge-focused Recruiting nowThis study screens 2,000 adults with newly diagnosed acute myeloid leukemia or myelodysplastic syndrome. Researchers test blood and bone marrow for specific markers to see if participants can join a treatment trial that targets their cancer type. The goal is to make the matching …
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC
-
New screening trial aims to match kids with relapsed leukemia to better treatments
Knowledge-focused Recruiting nowThis study screens children and young adults (up to age 22) whose leukemia has returned or is difficult to treat. By testing their blood and bone marrow, doctors look for specific genetic markers to match them with the most promising experimental treatments. The goal is to improv…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC